Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference

Audio By Carbonatix

CHICAGO--(BUSINESS WIRE)--Sep 3, 2025--

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference. The conference will take place September 8-10 in New York City. Eric Lefkofsky, Founder and CEO of Tempus, and Jim Rogers, Chief Financial Officer, will participate in a fireside chat on September 8 from 1:05 to 1:40 p.m. EST.

A live audio webcast of the conversation will be available here.

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250903424068/en/

CONTACT: Hanah Heintzelman

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS

INDUSTRY KEYWORD: APPS/APPLICATIONS TECHNOLOGY HEALTH TECHNOLOGY PROFESSIONAL SERVICES SOFTWARE NETWORKS GENERAL HEALTH DATA ANALYTICS HEALTH ARTIFICIAL INTELLIGENCE

SOURCE: Tempus AI, Inc.

Copyright Business Wire 2025.

PUB: 09/03/2025 04:01 PM/DISC: 09/03/2025 04:01 PM

http://www.businesswire.com/news/home/20250903424068/en